找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Applications of Enzyme Biotechnology; Jeffery W. Kelly,Thomas O. Baldwin Book 1991 Springer Science+Business Media New York 1991 Expressio

[复制链接]
楼主: 抵押证书
发表于 2025-3-26 21:02:40 | 显示全部楼层
发表于 2025-3-27 01:47:44 | 显示全部楼层
Additivity Failure for Brightnessmary or metastatic carcinoma. This chapter will cover the basic principles of antibodies, subsequent conjugation with bifunctional chelates and radiolabeling for the purpose of radioimmunoimaging or radioimmunotherapy.
发表于 2025-3-27 07:56:16 | 显示全部楼层
发表于 2025-3-27 10:41:34 | 显示全部楼层
Encyclopedia of Color Science and Technologyal models to solve these problems, to pave the way for clinical use of MAbs in patients. To illustrate the problems inherent in the development of radiolabeled MAbs for clinical use, we will present our work utilizing MAbs in a variety of brain tumor models.
发表于 2025-3-27 14:11:11 | 显示全部楼层
发表于 2025-3-27 20:32:14 | 显示全部楼层
https://doi.org/10.1007/978-3-031-23161-2 large-scale fermentation, the relative ease of their physical and chemical manipulation, and their generally simpler genetic makeup which makes cloning of the enzyme genes potentially easier and more straightforward.
发表于 2025-3-28 01:17:28 | 显示全部楼层
Radiolabeled Antibodies: Introduction and Metal Conjugation Techniquesmary or metastatic carcinoma. This chapter will cover the basic principles of antibodies, subsequent conjugation with bifunctional chelates and radiolabeling for the purpose of radioimmunoimaging or radioimmunotherapy.
发表于 2025-3-28 03:08:00 | 显示全部楼层
发表于 2025-3-28 08:45:19 | 显示全部楼层
Diagnosis and Therapy of Brain Tumors Utilizing Radiolabeled Monoclonal Antibodiesal models to solve these problems, to pave the way for clinical use of MAbs in patients. To illustrate the problems inherent in the development of radiolabeled MAbs for clinical use, we will present our work utilizing MAbs in a variety of brain tumor models.
发表于 2025-3-28 12:31:12 | 显示全部楼层
Isolation and Characterization of Natural and Recombinant Cyclophilinsas the binding proteins for the potent immunosuppressant FK-506 and its analogs (52–54). Although Cyp and FKBP are both PPIases, they apparently do not have the same specificity for peptide substrates (16) and Cyp will not bind FK-506 nor will FKBP bind CsA (52, 53).
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-7 00:40
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表